Dermira believes that compliance with applicable laws, regulations and company policies and directives is a critical component of our ability to bring important new treatments for chronic skin conditions to patients.
The purpose of our Comprehensive Compliance Program is to ensure that we fulfill our promise to patients as well as our employees, stakeholders, investors and the communities in which we serve by committing to the highest standards of ethical behavior. We believe that our behavior reflects who we are at Dermira. We recognize that a robust compliance program is key to maintaining the trust of the public and the respect of the industry, and our Comprehensive Compliance Program is an essential component of our Vision to become the most trusted, respected and innovative dermatology company in the world. Our goal is to be recognized by patients, providers and payers for delivering superior value, and by employees, partners and investors for having a great corporate culture, partner relations and customer service.
In 2003, the U.S. Department of Health and Human Services’ Office of Inspector General (OIG) published the OIG Compliance Program Guidance for Pharmaceutical Manufacturers (OIG Guidance). The OIG Guidance describes seven widely recognized and fundamental elements of an effective compliance program (listed below), which serve as the foundation for our Comprehensive Compliance Program.
- Core elements of an effective compliance program
- Written policies and procedures
- Designated compliance officer and compliance committee
- Effective training and education
- Effective lines of communication
- Internal monitoring and auditing
- Enforcement of standards through well-publicized disciplinary guidelines
- Prompt response to detected problems through corrective actions
Two critical components of our Comprehensive Compliance Program are our Code of Business Conduct and Ethics and our Compliance Hotline.
Dermira’s Code of Business Conduct and Ethics
The Code contains basic guidelines and requirements for ethical behavior. To view the Code, click here.
California Declaration of Compliance
To conduct our business with integrity and ethically, Dermira has established a Healthcare Compliance Program which serves as a Comprehensive Compliance Program in California. This program has been developed in accordance with the laws applicable to our industry, the “Program Guidance for Pharmaceutical Manufacturers” published by the Office of the Inspector General of the U.S. Department of Health and Human Services and the Code of Interactions with Healthcare Professionals of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Read more here.
Reporting a Concern
Dermira has established primary avenues for our employees, vendors and others to raise matters of concern related to the way the Company is conducting its business, such as a suspected breach of ethics, compliance requirements, financial accounting principles or company policy. Individuals may report the suspected violation by the following means:
Contacting the Compliance Hotline
Main Number: 866-354-3854
Available 24 hours a day, 7 days a week
Dermira takes all reports seriously and handles reports on a case-by-case basis. Investigations are handled in as confidential a manner as possible under the circumstances. After a thorough investigation, the Company will determine whether misconduct has occurred and will take appropriate action to address any confirmed misconduct and prevent its recurrence. Reports may be made confidentially and anonymously, though it is important to provide sufficient details to enable the Company to investigate the matter fully and to take appropriate corrective action as needed.
Dermira policy prohibits retaliation against employees who report suspected misconduct in good faith.